Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: A validation study based on follow-up

Digestive and Liver Disease

Volumn 37, Issue 10, 2005, Pages 779-785

  Giannini, E G ^a   Botta, F ^a   Borro, P ^a   Dulbecco, P ^a   Testa, E ^a   Mansi, C ^a   Savarino, V ^a   Testa, R ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Cirrhosis; Diagnosis; Oesophageal varices; Platelets; Spleen; Surveillance

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; ESOPHAGUS VARICES; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HUMAN; LIVER CIRRHOSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROGNOSIS; SPLEEN SIZE; THROMBOCYTE COUNT; VALIDATION PROCESS; AGED; BLOOD; COMPARATIVE STUDY; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; ROC CURVE; SPLEEN; VALIDATION STUDY;

AGED; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; ROC CURVE; SPLEEN;

EID: 33744739523     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2005.05.007     Document Type: Article

References (34)

1. Jensen D.M. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology 122 (2002) 1620-1630
2. Fattovich G., Pantalena M., Zagni I., Realdi G., Schalm S.W., and Christensen E. European concerted action on viral hepatitis (EUROHEP). Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients. Am J Gastroenterol 97 (2002) 2886-2895
3. Merkel C., Marin R., Angeli P., Zanella P., Felder M., Bernardinello E., et al. A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology 127 (2004) 476-484
4. de Franchis R., Pascal J.P., Ancona E., Burroughs A.K., Henderson M., Fleig W., et al. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol 15 (1992) 256-261
5. Grace N.D. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol 92 (1997) 1081-1091
6. Grace N.D., Groszmann R.J., Garcia-Tsao G., Burroughs A.K., Pagliaro L., Makuch R.W., et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 28 (1998) 868-880
7. Talwalkar J.A., and Kamath P.S. Screening for esophageal varices among patients with cirrhosis of the liver. Am J Gastroenterol 96 (2001) 3039-3040
8. Chalasani N., Imperiale T.F., Ismail A., Sood G., Carey M., Wilcox C.M., et al. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol 94 (1999) 3285-3291
9. Zaman A., Hapke R., Flora K., Rosen H.R., and Benner K. Factors predicting the presence of esophageal varices or gastric varices in patients with advanced liver disease. Am J Gastroenterol 94 (1999) 3292-3296
10. Pilette C., Oberti F., Aubé C., Rousselet M.C., Bedossa P., Gallois Y., et al. Non-invasive diagnosis of esophageal varices in chronic liver disease. J Hepatol 31 (1999) 867-873
11. Ng F.H., Wong S.Y., Loo C.K., Lam K.M., Lai C.W., and Cheng C.S. Prediction of oesophagogastric varices in patients with cirrhosis. J Gastroenterol Hepatol 14 (1999) 785-790
12. Schepis F., Cammà C., Niceforo D., Magnano A., Pallio S., Cinquegrani M., et al. Which patients should undergo endoscopic screening for esophageal varices detection?. Hepatology 33 (2001) 333-338
13. Zaman A., Becker T., Lapidus J., and Benner K. Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med 161 (2001) 2564-2570
14. Madhotra R., Mulcahy H.E., Willner I., and Reuben A. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol 34 (2002) 81-85
15. Zein C.O., Lindor K.D., and Angulo P. Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis. Hepatology 39 (2004) 204-210
16. Peck-Radosavljevic M. Thrombocytopenia in liver disease. Can J Gastroenterol 14 Suppl. D (2000) 60D-66D
17. Giannini E., Botta F., Borro P., Malfatti F., Fumagalli A., Testa E., et al. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection. Am J Gastroenterol 98 (2003) 2516-2520
18. McCormick P.A. The spleen, hypersplenism, and other relationships between the liver and spleen. In: Bircher J., Benhamou J.-P., McIntyre N., Rizzetto M., and Rodés J. (Eds). Oxford textbook of clinical hepatology (1999), Oxford University Press, Oxford 787-795
19. Giannini E., Botta F., Borro P., Risso D., Romagnoli P., Fasoli A., et al. Platelet count spleen/diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 52 (2003) 1200-1205
20. Zimbwa T.A., Blanshard C., and Subramaniam A. Platelet count/spleen diameter ratio as a predictor of oesophageal varices in alcoholic cirrhosis. Gut 53 (2004) 1055
21. Justice A.C., Covinsky K.E., and Berlin J.A. Assessing the generalizability of prognostic information. Ann Intern Med 130 (1999) 515-524
22. de Franchis R., Dell'Era A., and Iannuzzi F. Diagnosis and treatment of portal hypertension. Dig Liver Dis 36 (2004) 787-798
23. Ghosh A.K. Refusal of endoscopy in cirrhotic patients with Child-Pugh class A without prior variceal bleeding: an internist dilemma. Arch Intern Med 162 (2002) 947-948
24. Cales P., Desmorat H., Vinel J.P., Caucanas J.P., Ravaud A., Gerin P., et al. Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding. Gut 31 (1990) 1298-1302
25. Gentilini P., Laffi G., La Villa G., Romanelli R.G., Buzzelli G., Casini-Raggi V., et al. Long course and prognostic factors of virus-induced cirrhosis of the liver. Am J Gastroenterol 92 (1997) 66-72
26. Merli M., Nicolini G., Angeloni S., Rinaldi V., De Santis A., Merkel C., et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 38 (2003) 266-272
27. Pockros P.J., Duchini A., McMillan R., Nyberg L.M., McHutchison J., and Viernes E. Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. Am J Gastroenterol 97 (2002) 2040-2045
28. Liangpunsakul S., Ulmer B.J., and Chalasani N. Predictors and implications of severe hypersplenism in patients with cirrhosis. Am J Med Sci 326 (2003) 111-116
29. Tamayo S.G., Rickman L.S., Mathews W.C., Fullerton S.C., Bartok A.E., Warner J.T., et al. Examiner dependence on physical diagnostic tests for the detection of splenomegaly: a prospective study with multiple observers. J Gen Intern Med 8 (1993) 69-75
30. O'Donohue J., Ng C., Catnach S., Farrant P., and Williams R. Diagnostic value of Doppler assessment of the hepatic and portal vessels and ultrasound of the spleen in liver disease. Eur J Gastroenterol Hepatol 16 (2004) 147-155
31. Winkfield B., Aubé C., Burtin P., and Cales P. Inter-observer and intra-observer variability in hepatology. Eur J Gastroenterol Hepatol 15 (2003) 959-966
32. Arguedas M.R., Heudebert G.R., Eloubeidi M.A., Abrams G.A., and Fallon M.B. Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices. Am J Gastroenterol 97 (2002) 2441-2452
33. Spiegel B.M., Targownik L., Dulai G.S., Karsan H.A., and Gralnek I.M. Endoscopy screening for esophageal varices in cirrhosis: is it ever cost-effective?. Hepatology 37 (2003) 366-377
34. Giannini E., Botta F., and Testa R. Prediction of oesophageal varices with platelet count/spleen diameter ratio or platelets alone. Gut 53 (2004) 914-915